The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I dose-escalation and pharmacokinetic (PK) study of regorafenib in pediatric patients with recurrent or refractory solid malignancies.
 
Birgit Geoerger
No Relationships to Disclose
 
Bruce Morland
Honoraria - Takeda
 
Irene Jimenez
Travel, Accommodations, Expenses - Chugai Pharma
 
Didier Frappaz
No Relationships to Disclose
 
Andrew DJ Pearson
Honoraria - Boehringer Ingelheim; Genentech
Consulting or Advisory Role - Boehringer Ingelheim; Genentech
 
Gilles Vassal
Research Funding - Bayer
 
Patricia Maeda
Employment - Bayer
 
Jasmine Kincaide
Employment - Bayer
 
Udo Mueller
Employment - ClinStat
Consulting or Advisory Role - Bayer (Inst)
 
Sarah Schlief
Employment - Bayer
 
Adriaan Cleton
Employment - AstraZeneca; Bayer
Stock and Other Ownership Interests - AstraZeneca; Bayer; Pfizer
 
Andrea Chassot-Agostinho
Employment - Bayer
Travel, Accommodations, Expenses - Bayer
 
Lynley V Marshall
Honoraria - GlaxoSmithKline; Lilly
Consulting or Advisory Role - GlaxoSmithKline; Lilly
Travel, Accommodations, Expenses - Novartis; Roche/Genentech